Biological and clinical significance of clonogenic assays in patients with myelodysplastic syndromes

Medical Oncology

Volumn 19, Issue 4, 2002, Pages 249-259

  Marisavljević, Dragomir ^a   Rolovic Z ^a   Sefer D ^a   Basara, N ^a   Ilic D ^b   Boskovic D ^a   Colovic M ^a  

^a CLINICAL CENTER OF SERBIA   (Serbia)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Biology; Hematopoietic progenitors; In vitro assay; Myelodysplastic syndromes; Prognosis

Indexed keywords

CASPASE 3; CD34 ANTIGEN; ERYTHROPOIETIN; FAS ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEMOGLOBIN; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BONE MARROW CELL; BURST FORMING UNIT E; CELL CULTURE; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHRONIC MYELOMONOCYTIC LEUKEMIA; CLONOGENIC ASSAY; COLONY FORMATION; COLONY FORMING CELL; COLONY FORMING UNIT GM; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE RESPONSE; ELECTROIMMUNOASSAY; ERYTHROID CELL; ERYTHROPOIESIS; FEMALE; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; LEUKEMIA; MAJOR CLINICAL STUDY; MALE; MEGAKARYOCYTE; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; PROGNOSIS; REFRACTORY ANEMIA; SCORING SYSTEM; SIDEROBLASTIC ANEMIA; SURVIVAL; THROMBOCYTE COUNT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD34; APOPTOSIS; CHROMOSOME ABERRATIONS; COLONY-FORMING UNITS ASSAY; CYTOKINES; FEMALE; HEMATOPOIETIC STEM CELLS; HUMANS; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES;

EID: 0036913588     PISSN: 13570560     EISSN: None     Source Type: Journal    
DOI: 10.1385/MO:19:4:249     Document Type: Article

References (35)

1. Yoshida, Y., Stephenson, J. and Mufti, G.J. (1993). Myelodysplastic syndromes: From morphology to molecular biology. Part I. Classification, natural history and cell biology of myelodysplasia. Int. J. Hematol. 57:87-97.
2. Raymakers, R., Preijers, F., Boezeman, J., Rutten, E. and De Witte, T. (1993). Prognostic implications of bone marrow culturing in myelodysplastic syndrome: A retrospective analysis. Leuk. Lymphoma 14:111-120.
3. Pierre, R., et al. (1989). Clinical-Cytogenetic correlations in myelodysplasia (preleukemia). Cancer Genet. Cytogenet. 40:149-161.
4. Morel, P., et al. (1993). Cytogenetic analysis has strong independent prognostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system: A report on 408 cases. Leukemia 7:1315-1323.
5. Greenberg, P., et al. (1997). International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 89:(6)2079-2088.
6. Guyotat, D., et al. (1990). Myelodysplastic syndromes: A study of surface markers and in vitro growth patterns. Am. J. Hematol. 34:26-31.
7. Shihab-El-Deen, A., Guevara, C. and Prchal, J. (1987). Bone marrow cultures in dysmyelopoietic syndrome: Diagnostic and prognostic evaluation. Acta Haematol. (Basel) 78:17-24.
8. Verma, D., Spitzer, G., Dicke, K. and McCredie, K. (1979). In vitro agar culture patterns in preleukemia and their clinical significance. Leuk. Res. 3:41-49.
9. May, S., Smit, S., Jacobs, A., Williams, A. and Bailey-Wood, R. (1985). The myelodysplastic syndromes: analysis of laboratory characteristics in relation to the FAB classification. Br. J. Haematol. 59:311-319.
10. Greenberg, P. (1986) In vitro culture techiques defining biological abnormalities in the myelodysplastic syndromes and myeloproliferative disorders. Clin. Haematol. 15:973-993.
11. Yoshida, Y., et al. (1989). Prognostic implication of sequential bone marow cultures in the myelodysplastic syndromes. Leuk. Res. 13:967-972.
12. Tennant, G.B. and Jacobs, A. (1988) Undetectable peripheral blood CFU-GM as a prognostic indicator in myelodysplastic syndrome. Leuk. Res. 12:961-962.
13. Bianchi de Di Risio, C., Gronda, M., Malka, A., Barbich, M. and Santarelli, M. (1990). The myelodysplastic syndrome: Prognostic factors in relation to the "in vitro" clonogenic assay. Folia Haematol. 117(1):141-150.
14. Tennant, G., Bowen, D. and Jacobs, A. (1991). Colony-cluster ratio and cluster number in cultures of circulating myeloid progenitors as indicators of high-risk myelodysplasia. Br. J. Haematol. 77:296-300.
15. Boogaerts, M., Verhoef, G. and Demuynck, H. (1996). Treatment and prognostic factors in myelodysplastic syndromes. Bailliere's Clin. Haematol. 9(1):161-183.
16. Bennett, J., et al. (1982). FAB cooperative Group. Proposals for the classification of the myelodysplastic syndromes. Br. J. Haematol. 51:189-199.
17. Reizenstein, P. and Ost, A. (1992). Minimal diagnostic criteria for the myelodysplastic syndrome in clinical practice. Leuk. Res. 16(1):3-11.
18. Iscove, N., Sieber, F. and Winterhalter, K. (1974). Erythroid colony formation in culturs of mouse and human bone marrow: analysis of the requirements of erythropoietin by gel filtration and affinity chromatography on agarose- concavalin A. J. Cell Physiol. 83:309-315.
19. Messner, H., Jamal, N. and Izaguirre, C. (1982). The growth of large megakaryioocyte colonies from human bone marrow. J. Cell Physiol. 91(Suppl. 1):45-51.
20. Novak, A., Kruškić, M., Ludoški, M. and Jurkovski, V. (1994). Rapid method for obtaining high quality chromosome banding in the study of hemopoietic neoplasia. Cancer Genet. Cytogenet. 74(6):109-114.
21. Bagby, G., Gabourel, J. and Linman, J. (1980). Glucocorticoid therapy in the preleukemic syndrome (Hemopoietic dysplasia). Ann. Intern. Med. 92:55-58.
22. Molldrem, J.J., et al. (1998). Haematiological responsse of patients with myelodysplastic syndrome to antithymocyte globulin is associated with a loss of lymphocyte-mediated infhibition of CFU-GM and alternations in T-cell receptor Vbeta profiles. Br. J. Hematol. 102(5):1314-1322.
23. Baines, P., Bowen, D. and Jacobs, A. (1990). Clonal growth of hemopoietic progenitor cell from myelodysplastic marrow in response to recombinant haemopoietins. Leuk. Res. 14:247-253.
24. Haak, H., et al. (1986). Significance of in vitro cultures in myelodysplastic syndromes. Scand J Haematol 1986; 37:380-389.
25. Del Canizo, M.C., et al. (1998). The value of cell cultures for the diagnosis of mixed myelodysplastic myeloproliferative disorders. Haematologica 83(1):3-7.
26. Verhoef, G., et al. (1992). Measurement of serum cytokine levels in patients with myelodysplastic syndromes. Leukemia 6:1268-1272.
27. Zwerzina, H., Schollenberger, S., Herold, M., Schamalzl, F. and Besemer, J. (1992). Endogenous serum levels and surface receptor expression of GM-CSF and IL-3 in patients with myelodysplastic syndromes. Leuk. Res. 16:1181-1186.
28. Oscier, D., Worsley, A., Darlow, S., Figes, A., Williams, D. and Hamblin, T. (1989). Correlation of bone marrow colony growth in myelodysplastic syndromes with the FAB classification and the Bournemouth score. Leuk. Res. 13:833-839.
29. Merchav, S., et al. (1990). In vitro studies of erythropoietin dependent regulation of erythoropoiesis in myelodysplastic syndromes. Leukemia 4:771-776.
30. Amenomori, T., et al. (1986). Cytogenetic evidence for partially committed myeloid progenitor cell origin of chronic myelomonocytic leukemia and juvenile chronic myeloid leukaemia: Both granulocyte-macrophage precusors and erythroid precusors carry identical marker chromosoms. Br. J. Hematol. 64:539-545.
31. Swolin, B., et al. (1993). Variable growth in vitro of chromosomally different stem cells in myelodysplastic syndrome. Leuk. Res. 17(11):927-932.
32. Dupont, J.M., et al. (1998). Fluorescence in situ hybridization on methylcellulose cultured hematopoietic stem cells from myelodysplastic syndromes. Cancer Genet. Cytogenet. 101(1):12-15.
33. Raza, A., et al. (1996). A paradigm shift in myelodysplastic syndromes. Leukemia 10:1648-1652.
34. Sanz, G. and Sanz, A. (1992). Prognostic factors in in myelodysplastic syndromes. Leuk. Res. 1992; 16:77-86.
35. Juvonen, E., Aimolahti, A., Volin, L. and Ruutu, T. (1999). The prognostic value of in vitro cultures of erythroid and megakaryocyte progenitors in myelodysplastic syndromes. Leuk. Res. 23(10):889-894.